Freeze-dried haemophilus influenzae type B combined vaccine (Aimei Weixin BioPharm)

冻干b型流感嗜血杆菌结合疫苗 (艾美坚持生物)

Report date: 2025/08/20 14:02:12

Base Information

Drug NameFreeze-dried haemophilus influenzae type B combined vaccine (Aimei Weixin BioPharm)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd
Inactive CompaniesN/A
Active IndicationsHaemophilus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A